AMVRX
Price
$16.88
Change
-$0.10 (-0.59%)
Updated
Sep 20 closing price
JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

AMVRX vs JVMTX

Header iconAMVRX vs JVMTX Comparison
Open Charts AMVRX vs JVMTXBanner chart's image
American Century Mid Cap Value R
Price$16.88
Change-$0.10 (-0.59%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AMVRX vs JVMTX Comparison Chart
Loading...
VS
AMVRX vs. JVMTX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMVRX is a StrongBuy and JVMTX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. AMVRX (8.69B). AMVRX pays higher dividends than JVMTX: AMVRX (1.20) vs JVMTX (0.73). AMVRX was incepted earlier than JVMTX: AMVRX (19 years) vs JVMTX (11 years). AMVRX is a more actively managed with annual turnover of: 64.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than AMVRX: JVMTX (0) vs AMVRX (2500). JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. AMVRX (15.52). JVMTX return over 5 years is better than : 43.64 vs. AMVRX (11.47).
AMVRXJVMTXAMVRX / JVMTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years11 years-
Gain YTD10.11211.01092%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.69B23.4B37%
Annual Yield % from dividends1.200.73165%
Returns for 1 year15.5219.2781%
Returns for 3 years-7.9113.38-59%
Returns for 5 years11.4743.6426%
Returns for 10 years7.8063.3412%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems